Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand.

Conclusions. In Thailand, denosumab offers a cost-effective osteoporosis treatment option versus no pharmacologic treatment in postmenopausal women at high risk of fracture. PMID: 32063082 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research